Integrated Filing — IndAS



General information about company

Scrip Code 524558
NSE Symbol NEULANDLAB
MSEI Symbol NOTLISTED
ISIN INE794A01010
Name of company NEULAND LABORATORIES LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 12-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 20-04-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Manufacturing of Active Pharmaceuticals
Start date and time of board meeting 12-05-2026   14:15:00
End date and time of board meeting 12-05-2026   15:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 77,625.03 2,02,298.54
Other income 1,245.82 3,016.62
Total income 78,870.85 2,05,315.16
2 Expenses
(a) Cost of materials consumed 23,078.87 81,976.45
(b) Purchases of stock-in-trade 0.00 0.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade 3,850.21 (6,426.23)
(d) Employee benefit expense 9,847.17 34,114.14
(e) Finance costs 720.51 2,394.74
(f) Depreciation, depletion and amortisation expense 2,508.89 9,173.95
(f) Other Expenses
1 Manufacturing expense 5,172.22 19,161.44
2 Other expenses 4,943.50 16,022.96
Total other expenses 10,115.72 35,184.40
Total expenses 50,121.37 1,56,417.45
3 Total profit before exceptional items and tax 28,749.48 48,897.71
4 Exceptional items 0.00 0.00
5 Total profit before tax 28,749.48 48,897.71
6 Tax expense
7 Current tax 7,682.21 12,895.54
8 Deferred tax (199.99) (397.67)
9 Total tax expenses 7,482.22 12,497.87
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 21,267.26 36,399.84
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 21,267.26 36,399.84
17 Other comprehensive income net of taxes 123.66 106.41
18 Total Comprehensive Income for the period 21,390.92 36,506.25
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 21,267.26 36,399.84
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 21,390.92 36,506.25
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 1,290.05 1,290.05
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 1,86,073.35
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 165.76 283.71
Diluted earnings (loss) per share from continuing operations 165.76 283.71
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 165.76 283.71
Diluted earnings (loss) per share from continuing and discontinued operations 165.76 283.71
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. The financial results for the quarter and year ended March 31, 2026 have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 12, 2026. The Statutory Auditors have issued an unmodified audit opinion on the financial results for the year ended March 31, 2026 and have issued an unmodified conclusion in respect of limited review for the quarter ended March 31, 2026. 2. The financial results have been prepared in accordance with the Indian Accounting Standards (Ind AS) prescribed under Section 133 of the Companies Act, 2013, and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. The consolidated financial results include results of the following wholly owned subsidiaries: (a) Neuland Laboratories Inc., USA (b) Neuland Laboratories KK., Japan. 4. Segment Reporting 5. i. Segment information presented for the consolidated financial results as permitted under the Ind AS - 'Operating Segments. ii. The management has assessed the identification of reportable segments in accordance with the requirements of Ind AS 108 ‘Operating Segment’ and believes that the Group has only one reportable segment namely manufacture of active pharmaceutical ingredients and allied services”. Geography-wise details of the Company’s revenues from external customers and its non-current assets (excluding financial assets) are disclosed above. 6. During the previous year, the Company has fully transferred an investment property located in Nanakramguda, Hyderabad, Telangana, through perpetual lease, resulting in total profit of Rs. 7,640.36 lakhs (For the quarter ended June 30, 2024: Rs. 2,062.56 lakhs and for the quarter ended December 31, 2024: Rs. 5,577.80 lakhs) being the profit is exceptional in nature, it has been disclosed as a separate line item. 7. The EPS for quarters has not been annualised. 8. The Board of Directors has recommended a final dividend of Rs. 34/- (Rupees Thirty Four) only per equity share of Rs. 10 each subject to approval of shareholders for the year ended March 31, 2026. 9. The figures for the quarter ended March 31, 2026 and March 31, 2025 are the balancing figures between the audited figures in respect of the full financial year and published unaudited figures upto nine months of the relevant financial year.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 89,228.76
Capital work-in-progress 20,949.90
Investment property 0.00
Goodwill 27,946.10
Other intangible assets 518.12
Intangible assets under development 108.46
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 0.00
Non-current financial assets
Non-current investments 198.22
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Security deposits 1,194.81
Total of other non-current financial assets 1,194.81
Total non-current financial assets 1,393.03
Deferred tax assets (net) 0.00
Other non-current assets
1 Prepaid expenses 15.77
2 Capital advances 4,121.11
3 Balances with government authorities 23.37
4 Income Tax Assets (Net) 396.27
Total of other non-current assets 4,556.52
Total non-current assets 1,44,700.89
2 Current assets
Inventories 51,028.64
Current financial asset
Current investments 0.00
Trade receivables, current 54,135.31
Cash and cash equivalents 7,667.04
Bank balance other than cash and cash equivalents 27,829.45
Loans, current 0.00
Other current financial assets
Total of other current financial assets 433.81
Total current financial assets 90,065.61
Current tax assets (net) 0.00
Other current assets
1 Prepaid expenses 1,397.91
2 Advance to suppliers 1,145.16
3 Balances with government authorities 3,933.24
4 Export benefits receivable 740.38
5 Other advances 1.94
Total of other current assets 7,218.63
Total current assets 1,48,312.88
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 2,93,013.77
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,290.05
Other equity 1,86,157.24
Total equity attributable to owners of parent 1,87,447.29
Non controlling interest 0.00
Total equity 1,87,447.29
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 16,094.73
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liability 9,969.48
Total of other non-current financial liabilities 9,969.48
Total non-current financial liabilities 26,064.21
Provisions, non-current 1,586.11
Deferred tax liabilities (net) 6,896.36
Deferred government grants, Non-current 0.00
Other non-current liabilities
Total of other non-current liabilities
Total non-current liabilities 34,546.68
Current liabilities
Current financial liabilities
Borrowings, current 3,566.58
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,264.29
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 25,650.12
Total Trade payable 26,914.41
Other current financial liabilities
1 Interest accrued but not due on borrowings 5.88
2 Interest accrued on micro enterprises and small enterprises payable 5.87
3 Unclaimed dividends 23.28
4 Capital creditors 3,109.48
5 Employee benefits payable 3,891.85
6 Accrual for expenses 5,641.90
7 Lease Liability 496.43
Total of other current financial liabilities 13,174.69
Total current financial liabilities 43,655.68
Other current liabilities 25,317.78
1 Advance from customers 24,450.05
2 Liability towards Corporate Social Responsibility ('CSR') expenditure 13.83
3 Statutory liabilities 853.90
Total of other current liabilities 25,317.78
Provisions, current 230.78
Current tax liabilities (Net) 1,815.56
Deferred government grants, Current 0.00
Total current liabilities 71,019.80
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 1,05,566.48
Total equity and liabilites 2,93,013.77
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets null null
Net Segment Asset null null
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities null null
Net Segment Liabilities null null
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Re-measurement loss on defined benefit plans 65.65 1.65
2 Equity instruments through other comprehensive income 45.33 45.33
Total Amount of items that will not be reclassified to profit and loss 110.98 46.98
2 Income tax relating to items that will not be reclassified to profit or loss 27.93 11.82
3 Amount of items that will be reclassified to profit and loss
1 Exchange differences in translating the financial statements of foreign operations 40.61 71.25
Total Amount of items that will be reclassified to profit and loss 40.61 71.25
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 123.66 106.41



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 48,897.71
Adjustments for reconcile profit (loss)
Adjustments for finance costs 2,394.74
Adjustments for decrease (increase) in inventories (12,452.95)
Adjustments for decrease (increase) in trade receivables, current (22,421.18)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (291.48)
Adjustments for decrease (increase) in other non-current assets 8.52
Adjustments for other financial assets, non-current (718.29)
Adjustments for other financial assets, current (67.45)
Adjustments for other bank balances (3.40)
Adjustments for increase (decrease) in trade payables, current 1,614.91
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 17,391.81
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 9,173.95
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current 21.06
Adjustments for provisions, non-current 865.52
Adjustments for other financial liabilities, current 1,910.69
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 134.95
Adjustments for dividend income 0.00
Adjustments for interest income 1,005.54
Adjustments for share-based payments 0.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (432.76)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (3,876.90)
Net cash flows from (used in) operations 45,020.81
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) 10,352.77
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 34,668.04
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 92.63
Purchase of property, plant and equipment 39,016.77
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 587.98
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 108.46
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 26,523.74
Purchase of other long-term assets 15,000.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 860.74
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (15,137.19)
Net cash flows from (used in) investing activities (42,373.29)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 10,560.93
Repayments of borrowings 4,471.78
Payments of lease liabilities 747.76
Dividends paid 1,539.59
Interest paid 1,704.26
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities 2,097.54
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (5,607.71)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 81.71
Net increase (decrease) in cash and cash equivalents (5,526.00)
Cash and cash equivalents cash flow statement at beginning of period 13,193.04
Cash and cash equivalents cash flow statement at end of period 7,667.04





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates LLP, Chartered Accountants Yes 31-07-2027